Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517530
Status:
COMPLETED
Last Update Posted:
2016-10-11
First Post:
2007-08-16
Brief Title:
A Dose-Escalating Study of Obinutuzumab in Patients With B-lymphocyte Antigen CD20 Malignant Disease GAUGUIN
Sponsor:
Organization:
Hoffmann-La Roche